InsurTech SPACs face nail-biting redemption votes
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn

© 2024 Insider International Limited, company number 15236286, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian Group. All rights reserved.


Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

InsurTech SPACs face nail-biting redemption votes

Bernard Goyder
June 01, 2021
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
Hippo qomplx doma logos NYC 2.jpg

A trio of InsurTech special purpose acquisition company (SPAC) deals now face the prospect of investor redemptions, as a crucial equity market indicator points to muted support for the transactions among investors.

Hippo, Doma and Qomplx all agreed to merge with SPACs in early March, at a time when institutional investors were enthusiastically backing such deals at pumped up valuations.

Request a free trial:

Fuel a smarter strategy with our actionable market intelligence

    • Gain a competitive edge and accelerate decision-making
    • Be empowered by insights that transform confusion to clarity
    • Uncover growth opportunities and prepare for potential threats
Request a free trial Already a subscriber? Login now

Topics

NewsPersonal linesInsurTechSPACsMetromileHippoRootLemonade
BG
Bernard Goyder
Gift this article